IHC analysis of xenograft tumors indicated stronger staining of VEGFA and CD31 in LV-PDIA4 xenograft tumors (Fig. 5F-I), which indicated tumor-derived PDIA4 could promote VEGFA secretion and angiogenesis in vivo, as we had speculated. This evidence concerns the gene VEGFA and neoplasm.